Find uplifting stories about heroes, innovations, and solutions
14 results for "biontech"
BioNTech's experimental drug helped patients with aggressive lung cancer live a median of 18.5 months compared to 10 months with standard chemotherapy. The breakthrough could offer the first major improvement in treatment for this devastating disease in over a decade.
Three updated Covid vaccines just got FDA approval, bringing protection against the dominant XFG variant to vulnerable Americans. Manufacturers are ready to ship doses across the country right now.
A personalized cancer vaccine using the same mRNA technology that powered COVID vaccines just proved it works in major trials, tripling Moderna's stock price in one day. For melanoma patients, it's the breakthrough they've been waiting for.
A personalized mRNA vaccine from Moderna and Merck has shown remarkable five-year results against aggressive skin cancer. The therapy nearly halves the risk of melanoma returning after surgery.
Science journalist Matt Kaplan reveals how game-changing discoveries from DNA to mRNA vaccines initially faced fierce resistance, even from experts. His new book celebrates the persistence of scientists who proved the doubters wrong.
A groundbreaking cancer vaccine custom-built for each patient has prevented melanoma from returning in over 1,000 patients, opening doors for treatments against lung, bladder, kidney, and other cancers. Unlike chemotherapy that destroys healthy cells or broad immunotherapy, this vaccine teaches your immune system to hunt down mutations unique to your specific tumor.
After political backlash threatened to derail cancer research, mRNA vaccines are delivering real hope to patients with deadly diseases like pancreatic cancer. New funding and positive trial results suggest the technology could save thousands of lives.
A personalized mRNA vaccine helped eight pancreatic cancer patients generate powerful immune responses, and seven of them are still alive six years later. The breakthrough offers new hope for one of the deadliest cancers, where fewer than 13% of patients survive five years.
A groundbreaking report reveals that investing in African health research and development could generate $668 billion in GDP growth over the next two decades while creating millions of jobs. Every dollar invested would return $137 in economic value, proving health innovation is Africa's next economic frontier.
After a century with only one TB vaccine, three promising candidates are in final trials, led by South African researchers who could deliver a breakthrough by 2028. The new vaccines could prevent millions of deaths from a disease that still kills over 1.5 million people yearly.
A personalized mRNA vaccine is helping pancreatic cancer patients survive six years and counting, with nearly 90% of responders still alive. For a disease with just 13% five-year survival, this breakthrough offers real hope.
After 40 years without progress, researchers have developed drugs that are doubling survival times for pancreatic cancer patients. One experimental treatment helped half of patients live beyond 13 months, compared to just over six months with standard chemotherapy. ##
A personalized cancer vaccine from Moderna and Merck just proved it can train your immune system to fight melanoma tumors with pinpoint accuracy. Thousands of patients could benefit within years, with trials already underway for lung, pancreatic, and colon cancers.
After 40 years without progress, three experimental drugs are giving hope to pancreatic cancer patients, with one treatment doubling survival time from six months to over a year. The breakthroughs could transform one of the deadliest cancer diagnoses into a more manageable disease.